Christophe Borg
Impact in
- Oncology top 0.5%
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers
- Cancer Treatment and Pharmacology
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 174
- Colorectal Cancer Treatments and Studies 92
- Cancer Treatment and Pharmacology 36
- Cancer Immunotherapy and Biomarkers 34
- Pancreatic and Hepatic Oncology Research 27
- Hepatology 20
- Co-authors
- Olivier BouchéJaafar BennounaFrançois GhiringhelliThierry AndréEric Van CutsemCamille GrandclémentXavier PivotOlivier Adotévi
- Journals
- Journal of Clinical Oncology (47 papers)Annals of Oncology (27 papers)European Journal of Cancer (8 papers)OncoImmunology (7 papers)Frontiers in Oncology (7 papers)
- Partner nations
- FranceUnited StatesSpain
In The Last Decade
Christophe Borg
211 papers receiving 6.2k citations
Hit Papers
Peers
Comparison fields: 5 of 127
- Oncology 4.3k
- Hepatology 639
- Cancer Research 876
- Pulmonary and Respiratory Medicine 1.7k
- Immunology 1.1k
Countries citing papers authored by Christophe Borg
This map shows the geographic impact of Christophe Borg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christophe Borg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christophe Borg more than expected).
Fields of papers citing papers by Christophe Borg
This network shows the impact of papers produced by Christophe Borg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christophe Borg. The network helps show where Christophe Borg may publish in the future.
Co-authors
The 25 scholars most cited alongside Christophe Borg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 3 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 22 | |
| 8 | 2023 | 5 | |
| 9 | 2023 | 6 | |
| 10 | 2022 | 9 | |
| 11 | 2020 | 22 | |
| 12 | 2020 | 15 | |
| 13 | 2020 | 4 | |
| 14 | 2019 | 33 | |
| 15 | 2019 | 14 | |
| 16 | 2015 | 16 | |
| 17 | 2012 | 47 | |
| 18 | 2011 | 94 | |
| 19 | Immunothérapie fondée sur les cellules natural killer : implication des cellules dendritiques | 2003 | 1 |
| 20 | Introduction to the principles of chemotherapy dose intensity | 2001 | 1 |
About Christophe Borg
Christophe Borg is a scholar working on Oncology, Hepatology, Gastroenterology, Cancer Research and Immunology, having authored 227 papers that have together received 6.3k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (92 papers), Cancer Treatment and Pharmacology (36 papers), Cancer Immunotherapy and Biomarkers (34 papers), Gastric Cancer Management and Outcomes (32 papers), Cancer Genomics and Diagnostics (29 papers), Genetic factors in colorectal cancer (27 papers), Pancreatic and Hepatic Oncology Research (27 papers) and Colorectal and Anal Carcinomas (25 papers). The work is most often cited by research in Oncology (4.3k citations), Hepatology (639 citations), Cancer Research (876 citations), Pulmonary and Respiratory Medicine (1.7k citations) and Immunology (1.1k citations). Christophe Borg has collaborated with scholars based in France, United States and Spain. Frequent co-authors include Olivier Bouché, Jaafar Bennouna, François Ghiringhelli, Thierry André, Eric Van Cutsem, Camille Grandclément, Xavier Pivot, Olivier Adotévi, Irmarie Reyes‐Rivera and Javier Sastre. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, OncoImmunology and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.